Literature DB >> 16781900

A rapid reversed phase high-performance liquid chromatographic method for determination of sophoridine in rat plasma and its application to pharmacokinetics studies.

Yuhui Wei1, Xinan Wu, Xiaofeng Liu, Jianyun Luo.   

Abstract

A high-performance liquid chromatography (HPLC) method for determining sophoridine in rat plasma was developed for application in the pharmacokinetic studies. The plasma was deproteinized with acetonitrile that contained an internal standard (ephedrine) and was separated from the aqueous layer by adding sodium chloride and sodium carbonate. The HPLC assay was carried out using a YMC-ODS column. The mobile phase was methanol-ethanol-0.01 moll(-1) ammonium acetate buffer-triethylamine (10:0.5:89.5:0.03, v/v/v/v) (pH 6.80). The flow rate was 0.8 ml min(-1). The detection wavelength was set at 210 nm. The method was used to determine the concentration-time profiles of sophoridine in the plasma following oral administration or injection of sophoridine aqueous solution. The fractions of sophoridine reaching the systemic circulation were estimated for the first time by a deconvolution method.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781900     DOI: 10.1016/j.jchromb.2006.05.023

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Synthesis, Biological Evaluation, and Autophagy Mechanism of 12N-Substituted Sophoridinamines as Novel Anticancer Agents.

Authors:  Chongwen Bi; Na Zhang; Peng Yang; Cheng Ye; Yanxiang Wang; Tianyun Fan; Rongguang Shao; Hongbin Deng; Danqing Song
Journal:  ACS Med Chem Lett       Date:  2017-01-05       Impact factor: 4.345

2.  Pharmacokinetic study of 14-(3-methylbenzyl)matrine and 14-(4-methylbenzyl)matrine in rat plasma using liquid chromatography-tandem mass spectrometry.

Authors:  Minjie Jiang; Lisheng Wang; Shulin Huang; Liba Xu; Chao Hu; Weizhe Jiang
Journal:  PLoS One       Date:  2015-02-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.